XML 19 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Net Loss - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Revenue $ 1,420,680 $ 1,252,272
Cost of goods sold 487,024 447,192
Gross profit 933,656 805,080
General and administrative expense 10,932,125 10,351,973
Operations expense 2,698,565 2,351,709
Sales and marketing expense 774,530 584,937
Loss on goodwill impairment 2,813,792 12,876,498
Loss on impairment intangibles 2,893,548 0
Loss on impairment of software acquired 1,249,727 0
Total operating loss (20,428,631) (25,360,037)
Other income 184,528 843,440
Other expense (239,631) (2,427,026)
Loss on early extinguishment of debt 0 (1,996,681)
Gain on derivative instruments 164,902 1,765,907
Gain on notes receivables associated with asset purchase 0 1,290,000
Net loss before income tax benefit (20,318,832) (25,884,397)
Income tax benefit (661,658) 0
Net loss (19,657,174) (25,884,397)
Deemed dividend 0 554,287
Net loss attributable to common shareholders $ (19,657,174) $ (26,438,684)
Loss per common share - basic and diluted (in dollars per share) $ (0.36) $ (2.21)
Weighted average shares used in computation - basic and diluted (in shares) 54,876,044 11,950,154